Search Login Register
Allergic Conjunctivitis
(Giant Papillary Conjunctivitis)
Summary
Description:
Conjunctivitis due to hypersensitivity to various allergens.
Also Known As:
Giant Papillary Conjunctivitis; Vernal Keratoconjunctivitis; Conjunctivitis, Allergic; Allergic Conjunctivitides; Atopic Conjunctivitides Show All >>
Networked: 1113
relevant articles (194 outcomes,
228 trials/studies)
for this Disease
Key Drugs and Agents for Allergic Conjunctivitis
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Ophthalmic Solutions (Eye Drops)
:
29 outcomes 41 studies in 144 results
: IBA
-
olopatadine (Patanol)
:
25 outcomes 31 studies in 77 results
:
FDA 5
-
Cyclosporine (Ciclosporin)
:
23 outcomes 13 studies in 57 results
:
FDA 20
Generic
-
Cromolyn Sodium (Cromoglicic Acid)
:
16 outcomes 24 studies in 77 results
:
FDA 26
Generic
-
Nedocromil (Alocril)
:
12 outcomes 12 studies in 34 results
:
FDA 4
-
lodoxamide ethyl (lodoxamide)
:
11 outcomes 7 studies in 25 results
: IBA
-
Tacrolimus (Prograf)
:
11 outcomes 3 studies in 23 results
:
FDA 7
Generic
-
levocabastine (Bilina)
:
10 outcomes 21 studies in 50 results
:
FDA 1
-
Ketotifen (Ketotifene)
:
9 outcomes 10 studies in 28 results
:
FDA 5
-
epinastine
:
8 outcomes 8 studies in 16 results
:
FDA 3
Show All >>
Diseases Related to Allergic Conjunctivitis
-
Pruritus (Itching)
-
Hypersensitivity (Allergy)
-
Rhinitis
-
Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
-
Asthma (Bronchial Asthma)
Show All >>
Key Therapies for Allergic Conjunctivitis
Efficacy Chart >>
-
Immunotherapy
:
10 outcomes 6 studies in 29 results
-
Contact Lenses
:
2 outcomes 2 studies in 31 results
-
Hydrophilic Contact Lenses (Hydrophilic Contact Lens)
:
1 outcome 2 studies in 17 results
-
Transplantation (Transplant Recipients)
:
1 outcome 1 study in 9 results
-
Homologous Transplantation (Allograft)
:
1 outcome 1 study in 8 results
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.